Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.94 +0.07 (+1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Revenue (2022 - 2023)

Updated

Unicycive Therapeutics (UNCY) reported Revenue of $675,000 for FY2023, down 29.0% from $951,000 in FY2022.

Analysis

Unicycive Therapeutics (UNCY) Revenue (2022 - 2023) Analysis & Trends

  • According to Business Quant data, Revenue came in at $951,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 25.40 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 16.99 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 15.38 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 7.80 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 15.03 Bn
10 Unicycive Therapeutics 109.75 Mn -90.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 675,000.00
Sep 30, 2022 951,000.00
API Access

Unicycive Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=UNCY&period=max&api_key=YOUR_API_KEY